Apium Additive Technologies resumes search for investors

Apium Additive Technologies GmbH, based in Karlsruhe, has resumed its search for investors. “We are already successfully serving the industrial and medical markets worldwide with our existing 3D printers and would like to focus more on the medical sector. To this end, we want to qualify our latest product platform, the Apium P400 industrial 3D printer, which we have developed to market maturity in recent years, for the medical target market. To do this, we need fresh capital to enable us to take this step. Then we can reap the rewards of our development work over the past few months. However, our current investor cannot provide any additional funds for this,” explains Apium Managing Director Lars Pfotzer. “We have therefore decided to restructure our young company in insolvency proceedings and resume the search for investors.”

Apium Additive Technologies sees itself as a manufacturer of machine tools. “Our patented technology is one of the few manufacturing processes available on the market that is capable of processing high-performance thermoplastics to produce high-strength components that are proven to be suitable for the production of medical implants. Our customers are already successfully using our 3D printers to produce customized implant solutions according to medical specifications and on the basis of CT/MRI data, which can be inserted into the patient and enable faster treatment success compared to conventional methods. At the same time, medical research institutes use our products to develop and test materials and components so that they can later be used in everyday clinical practice,” says CEO Pfotzer.

Founded in 2016, the start-up Apium Additive Technologies now employs 15 people and recently generated annual sales of around one million euros. “I see great potential for Apium if an investor can be found to support the young company. The high cost of development work has meant that Apium is unable to fully exploit its potential in terms of market development and the further development of its products under the current ownership structure. The current provisional insolvency proceedings offer investors the opportunity to take over the company free of legacy burdens and lead it into the future,” says the provisional insolvency administrator appointed by Karlsruhe Local Court, Holger Blümle from the Karlsruhe office of the nationwide law firm Schultze & Braun.

Business operations at Apium Additive Technologies will continue without restrictions even after the insolvency application. “Our aim is to enter into negotiations with potential investors as soon as possible in order to be able to release Apium from the proceedings quickly,” says the provisional insolvency administrator Holger Blümle. The first expressions of interest have already been received.